Haemophilia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Haemophilia stocks.

Haemophilia Stocks Recent News

Date Stock Title
Oct 2 NVO European Equities Close Mostly Higher in Wednesday Trading; Euro Area Unemployment Unchanged in August
Oct 2 NVO Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
Oct 2 NVO Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
Oct 2 NVO Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
Oct 2 NVO Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Oct 2 NVO Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
Oct 1 NVO Novo Nordisk (NVO) Stock Moves -0.89%: What You Should Know
Oct 1 NVO U.S. port strike expected to have limited impact on healthcare supply chain: HHS
Oct 1 NVO Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
Sep 30 NVO Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
Sep 30 NVO Is Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?
Sep 29 NVO Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
Sep 29 NVO 'Stop Ripping Us Off' – Incredibly, Elon Musk And Bernie Sanders Seem To Agree On This One Thing – 'I Really Am With Bernie On This One'
Sep 28 NVO 15 Unhealthiest Countries in Europe
Sep 28 NVO Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
Sep 28 NVO Benzinga Bulls And Bears: Apple, Tesla, Novo Nordisk, Bitcoin — And Shiba Inu's Major Stablecoin Tease
Sep 27 NVO Novo Nordisk stock closes lower, analyst warns about Wegovy sales
Sep 27 NVO Top Midday Stories: Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug; Novo Nordisk Shares Drop After Analyst's Sales Concerns
Sep 27 NVO Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales
Sep 27 NVO Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
Haemophilia

Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding for a longer time after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain. Those with a mild case of the disease may have symptoms only after an accident or during surgery. Bleeding into a joint can result in permanent damage while bleeding in the brain can result in long term headaches, seizures, or a decreased level of consciousness.There are two main types of haemophilia: haemophilia A, which occurs due to low amounts of clotting factor VIII, and haemophilia B, which occurs due to low levels of clotting factor IX. They are typically inherited from one's parents through an X chromosome carrying a nonfunctional gene. Rarely a new mutation may occur during early development or haemophilia may develop later in life due to antibodies forming against a clotting factor. Other types include haemophilia C, which occurs due to low levels of factor XI, and parahaemophilia, which occurs due to low levels of factor V. Acquired haemophilia is associated with cancers, autoimmune disorders, and pregnancy. Diagnosis is by testing the blood for its ability to clot and its levels of clotting factors.Prevention may occur by removing an egg, fertilizing it, and testing the embryo before transferring it to the uterus. Treatment is by replacing the missing blood clotting factors. This may be done on a regular basis or during bleeding episodes. Replacement may take place at home or in hospital. The clotting factors are made either from human blood or by recombinant methods. Up to 20% of people develop antibodies to the clotting factors which makes treatment more difficult. The medication desmopressin may be used in those with mild haemophilia A. Studies of gene therapy are in early human trials.Haemophilia A affects about 1 in 5,000–10,000, while haemophilia B affects about 1 in 40,000, males at birth. As haemophilia A and B are both X-linked recessive disorders, females are rarely severely affected. Some females with a nonfunctional gene on one of the X chromosomes may be mildly symptomatic. Haemophilia C occurs equally in both sexes and is mostly found in Ashkenazi Jews. In the 1800s haemophilia B was common within the royal families of Europe. The difference between haemophilia A and B was determined in 1952. The word is from the Greek haima αἷμα meaning blood and philia φιλία meaning love.

Browse All Tags